| Trial ID: | L0357 |
| Source ID: | NCT00099723
|
| Associated Drug: |
VSL#3
|
| Title: |
The Effect of a Probiotic on Hepatic Steatosis
|
| Acronym: |
--
|
| Status: |
Terminated
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Drug: VSL#3
|
| Outcome Measures: |
MRI|Liver biopsy|Blood work
|
| Sponsor/Collaborators: |
VSL Pharmaceuticals
|
| Gender: |
All
|
| Age: |
45 Years to 70 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double|Primary Purpose: Treatment
|
| Start Date: |
October 2004
|
| Completion Date: |
December 2005
|
| Results First Posted: |
--
|
| Last Update Posted: |
February 11, 2010
|
| Locations: |
Johns Hopkins Hospital, Baltimore, Maryland, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00099723
|
